Lentivirus-mediated silencing of HOTAIR lncRNA restores gefitinib sensitivity by activating Bax/Caspase-3 and suppressing TGF-α/EGFR signaling in lung adenocarcinoma

Oncology Letters
Yuan-Shun LiuYa-Qing Li

Abstract

Secondary resistance is a major limitation in the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor treatment of lung cancer. Previous studies have shown that expression of the long non-coding RNA HOX transcript antisense RNA (HOTAIR) is upregulated in lung cancer, which is correlated with metastasis and poor prognosis. However, the precise role of HOTAIR and its effects on gefitinib resistance in human lung adenocarcinoma are not known. To address this issue, in the present study we established a gefitinib-resistant (R)PC-9 human lung adenocarcinoma cell line and examined cell viability with the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay. We found that gefitinib concentrations <10 µM inhibited the viability of PC-9 but not RPC-9 cells in a dose-dependent manner. Lentivirus-mediated HOTAIR RNA interference induced cell apoptosis and S-phase arrest, as determined by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling and flow cytometry. Consistent with these observations, HOTAIR suppression was associated with tumor shrinkage and restoration of gefitinib sensitivity in RPC-9 xenograft mice. Immunohistochemical analyses and western b...Continue Reading

References

Oct 26, 2000·Nature·M O Hengartner
Dec 6, 2002·Nature·Y OkazakiUNKNOWN RIKEN Genome Exploration Research Group Phase I & II Team
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Dec 27, 2005·Biochemical and Biophysical Research Communications·David B Whyte, Susan L Holbeck
Dec 13, 2007·Nature Reviews. Molecular Cell Biology·Rebecca C TaylorSeamus J Martin
Sep 26, 2008·The New England Journal of Medicine·Roy S HerbstScott M Lippman
May 19, 2009·Current Opinion in Cell Biology·Christopher A Brosnan, Olivier Voinnet
Jan 12, 2010·TheScientificWorldJournal·Daniel P CaleyDavid R F Carter
Nov 5, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Seiji YanoMasayuki Noguchi
Jul 13, 2012·Nature Reviews. Cancer·Yosef Yarden, Gur Pines
Sep 8, 2012·Nature·Sarah DjebaliThomas R Gingeras
Mar 9, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Helena A YuGregory J Riely
Mar 19, 2013·Cell·Pedro J Batista, Howard Y Chang
May 15, 2013·Journal of Hematology & Oncology·Yan ZhuangBin Shan
Mar 19, 2014·Seminars in Cell & Developmental Biology·Bhuminder Singh, Robert J Coffey
Jul 17, 2014·Neoplasma·B CaiS Zhang
Jan 20, 2015·Nature Genetics·Matthew K IyerArul M Chinnaiyan
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Sep 6, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jing LiXiaoying He
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Apr 25, 2020·International Journal of Molecular Sciences·Young-Ah KimSun-Jae Lee
Dec 12, 2018·Cell & Bioscience·Hu PengJiang-Feng Wu

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
flow cytometry
xenograft
Protein
electrophoresis
fluorescence microscopy

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.